HHcy-induced Bax upregulation, Treg apoptosis and vascular disease
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease
批准号:
8789814
负责人:
Xiaofeng Yang
金额:
$1.58万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-01 至 2017-03-31
关键词:
AccountingApolipoprotein EApoptosisArteriesAtherosclerosisAutoimmune ProcessBax proteinBinding ProteinsBiochemicalBiologicalBlood PressureBlood VesselsBone MarrowCardiovascular DiseasesCellsCessation of lifeCholesterolChronicCollaborationsCoronary heart diseaseCystathionineDNADNA MethylationDNA MethyltransferaseDNA Methyltransferase InhibitorDNA Modification MethylasesDataDevelopmentEventFunctional disorderFutureGenesGoalsHomocysteineHomocystineHumanHyperhomocysteinemiaHyperlipidemiaImmuneImmunosuppressionImmunosuppressive AgentsInflammationInflammatoryKnockout MiceLaboratoriesLeadLinkMapsMediatingMethylationMolecularMolecular TargetMorbidity - disease rateMusMyocardial InfarctionNeonatalPeripheralPeripheral arterial diseasePlasmaProteinsPublic HealthPublicationsRNARegulatory T-LymphocyteReportingRiskRisk FactorsRoleSmall Interfering RNASpleenStrokeSubarachnoid HemorrhageT-LymphocyteTestingTherapeuticTissuesTransgenesTransgenic MiceUp-RegulationVascular DiseasesViral VectorWaterbasechromatin immunoprecipitationinhibitor/antagonistinterestmortalitymouse modelnew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticsoverexpressionperipheral bloodpreventpromoterprotein expressionsuccessvascular inflammation
中文摘要
血浆同型半胱氨酸(Hcy)水平升高,称为高同型半胱氨酸血症(HHcy),是一种
是人类冠心病(CHD)和中风的独立危险因素。然而,生物化学
HHcy在血管炎症和动脉粥样硬化中的作用机制尚不清楚。
大多数免疫细胞促进炎症,而CD 4 + CD 25 highFoxp 3+调节性T细胞(TcB),
最有效的免疫抑制剂
细胞,抑制血管炎症。T细胞,而不是其他T细胞,
同型半胱氨酸(Hcy)降低,载脂蛋白升高
E缺乏(ApoE/
)
小鼠因此,HHcy促进了
Treg减少可能削弱免疫抑制并加速血管炎症。的目标
这个项目是为了检验我们的中心假设,即HHcy导致DNA甲基化的抑制,
它导致促凋亡蛋白的上调和激活,
蛋白Bax和Treg增加
细胞凋亡,并最终导致增加的血管炎症和功能障碍。本项目拟
基于Hong Wang博士(合作研究者)的开创性发现,
HHcy促进血管生成
胱硫醚合酶与炎症和动脉粥样硬化
(Cbs)/
/
ApoE/
双
敲除
(KO)小鼠
Wang的团队也是第一个证明HHcy导致SAH(S腺苷高半胱氨酸,
一
甲基转移酶的有效抑制剂)和DNA低甲基化。此外,我们的实验室长期以来
组织和血管中细胞凋亡途径研究兴趣和出版记录
炎症我们的目标将通过执行以下具体目标来实现:(1)描述
在HHcy小鼠中,脾脏、骨髓(BM)、外周血(PB)和动脉中的Treg凋亡(表型
研究)。(2)确定HHcy诱导的潜在机制
Treg细胞凋亡与血管炎症
(机械研究)。(3)确定DNA低甲基化的介导作用和
HHcy对Bax表达在TcG和Treg细胞凋亡中的作用(治疗/抑制研究)。该项目的成功是
这可能会导致新的治疗方法的发展,以抑制HHcy诱导的
Treg凋亡和增强Treg抑制HHcy诱导的血管炎症。
英文摘要
Elevated level of plasma homocysteine (Hcy), termed hyperhomocysteinemia (HHcy), is an
independent risk factor for human coronary heart disease (CHD) and stroke. However, the biochemical
mechanisms underlying the effects of HHcy in vascular inflammation and atherosclerosis are poorly defined.
The majority of immune cells promote inflammation whereas CD4+CD25highFoxp3+ regulatory T cells (Tregs),
the most potent immunosuppressive
cells, inhibit vascular inflammation. Tregs, but not other T cells, are
decreased in homocysteine (Hcy) elevatedapolipoprotein
E deficient (ApoE/
)
mice. Consequently, HHcypromoted
Treg reduction may weaken immune suppression and accelerate vascular inflammation. The goal of
this project is to examine our central hypothesis that HHcy causes the suppression of DNA methylation in
Tregs, which leads to upregulation and activation of proapoptotic
protein Bax in Tregs and increased Treg
apoptosis, and finally contribute to increased vascular inflammation and dysfunction. This project is proposed
based on the pioneer findings from Dr. Hong Wang (coinvestigator)¿
s laboratory that HHcy promotes vascular
inflammation and atherosclerosis in cystathionine βsynthase
(Cbs)/
/
ApoE/
double
knockout
(KO) mice.
Wang¿s team was also the first to show that HHcy leads to accumulation of SAH (Sadenosylhomocysteine,
a
potent inhibitor of methyltransferases) and DNA hypomethylation. In addition, our laboratory has a longstanding
interest and publication record in characterizing apoptosis pathways in Tregs and vascular
inflammation. Our goal will be pursued through the execution of the following specific aims: (1) Characterize
Treg apoptosis in the spleen, bone marrow (BM), peripheral blood (PB), and arteries in HHcy mice (phenotypic
studies). (2) Determine the mechanisms underlying HHcyinduced
Treg apoptosis and vascular inflammation
(mechanistic studies). (3) Determine the mediating role of DNA hypomethylation and the causative role of
HHcy on Bax expression in Tregs and Treg apoptosis (therapeutic/inhibitory studies). Success of this project is
significant, which may lead to the development of new therapeutic approaches to inhibit HHcyinduced
Treg apoptosis and enhance Treg suppression of HHcy-induced vascular inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LysoPI/GPR55 pathway promotes endothelial activation, vascular inflammation and atherosclerosis
-
批准号:10585541
-
项目类别:
-
资助金额:$65.45万
-
财政年份:2023
-
负责人:Xiaofeng Yang
-
依托单位:
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation
-
批准号:9764871
-
项目类别:
-
资助金额:$65.93万
-
财政年份:2019
-
负责人:Xiaofeng Yang
-
依托单位:
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation
-
批准号:10363670
-
项目类别:
-
资助金额:$64.82万
-
财政年份:2019
-
负责人:Xiaofeng Yang
-
依托单位:
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation
-
批准号:9912844
-
项目类别:
-
资助金额:$65.17万
-
财政年份:2019
-
负责人:Xiaofeng Yang
-
依托单位:
Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost
-
批准号:10330434
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2018
-
负责人:Xiaofeng Yang
-
依托单位:
Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost
-
批准号:10084277
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2018
-
负责人:Xiaofeng Yang
-
依托单位:
IL-35 suppression of endothelial cell activation and atherosclerosis
-
批准号:9261871
-
项目类别:
-
资助金额:$58.77万
-
财政年份:2016
-
负责人:Xiaofeng Yang
-
依托单位:
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease
-
批准号:8419884
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2013
-
负责人:Xiaofeng Yang
-
依托单位:
HHcy-induced Bax upregulation, Treg apoptosis and vascular disease
-
批准号:8666810
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2013
-
负责人:Xiaofeng Yang
-
依托单位:
Roles of Interleukin-17 in Endothelial Cells
-
批准号:8308370
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2011
-
负责人:Xiaofeng Yang
-
依托单位:
Roles of Interleukin-17 in Endothelial Cells
-
批准号:8469079
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2011
-
负责人:Xiaofeng Yang
-
依托单位:
Roles of Interleukin-17 in Endothelial Cells
-
批准号:8153046
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2011
-
负责人:Xiaofeng Yang
-
依托单位:
Roles of Interleukin-17 in Endothelial Cells
-
批准号:8675923
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2011
-
负责人:Xiaofeng Yang
-
依托单位:
Suppression of vascular endothelial cell inflammation
-
批准号:7891222
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Xiaofeng Yang
-
依托单位:
Suppression of vascular endothelial cell inflammation
-
批准号:8259154
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:Xiaofeng Yang
-
依托单位:
Suppression of vascular endothelial cell inflammation
-
批准号:7729713
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Xiaofeng Yang
-
依托单位:
Suppression of vascular endothelial cell inflammation
-
批准号:8066010
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Xiaofeng Yang
-
依托单位:
Suppression of vascular endothelial cell inflammation
-
批准号:8452070
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2009
-
负责人:Xiaofeng Yang
-
依托单位:
Survival of CD4+CD25+ Regulatory T Cells
-
批准号:6898135
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2003
-
负责人:Xiaofeng Yang
-
依托单位:
Survival of CD4+CD25+ Regulatory T Cells
-
批准号:6749006
-
项目类别:
-
资助金额:$11.12万
-
财政年份:2003
-
负责人:Xiaofeng Yang
-
依托单位:
海外基金